Aasaan Loans IPO vs Emcure Pharma IPO

Comparision between Aasaan Loans IPO and Emcure Pharma IPO.

IPO Details

Aasaan Loans IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Aasaan Loans IPO	Emcure Pharma IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Gretex Corporate Services Limited	Kotak Mahindra Capital Company Limited Axis Capital Limited J.P. Morgan India Private Limited Jefferies India Private Limited
Registrar	Bigshare Services Pvt Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Aasaan Loans IPO is up to ₹132.00 Cr whereas the issue size of the Emcure Pharma IPO is up to ₹1,952.03 Cr. The final issue price of Aasaan Loans IPO is ₹120.00 per share and of Emcure Pharma IPO is ₹1,008.00 per share.

	Aasaan Loans IPO	Emcure Pharma IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹114.00 per share	₹960.00 per share
Issue Price (Upper)	₹120.00 per share	₹1,008.00 per share
Issue Price (Final)	₹120.00 per share	₹1,008.00 per share
Discount (Retail)
Discount (Employee)		₹90.00 per share
Market Lot Size	125 shares	14 shares
Fresh Issue Size	1,10,00,000 shares	79,36,507 shares
Fresh Issue Size (Amount)	up to ₹132.00 Cr	up to ₹800.00 Cr
OFS Issue Size		1,14,28,839 shares
OFS Issue Size (Amount)		up to ₹1,152.03 Cr
Issue Size Total	1,10,00,000 shares	1,93,65,346 shares
Issue Size Total (Amount)	up to ₹132.00 Cr	up to ₹1,952.03 Cr

IPO Timetable

Aasaan Loans IPO opens on Jun 19, 2024, while Emcure Pharma IPO opens on Jul 03, 2024. The closing date of Aasaan Loans IPO and Emcure Pharma IPO is Jun 21, 2024, and Jul 05, 2024, respectively.

	Aasaan Loans IPO	Emcure Pharma IPO
Anchor Bid Date	Jun 18, 2024	Jul 02, 2024
Issue Open	Jun 19, 2024	Jul 03, 2024
Issue Close	Jun 21, 2024	Jul 05, 2024
Basis Of Allotment (Tentative)	Jun 24, 2024	Jul 08, 2024
Initiation of Refunds (Tentative)	Jun 25, 2024	Jul 09, 2024
Credit of Share (Tentative)	Jun 25, 2024	Jul 09, 2024
Listing date (Tentative)	Jun 26, 2024	Jul 10, 2024
Anchor Lockin End date 1	Jul 24, 2024	Aug 07, 2024
Anchor Lockin End date 2	Sep 22, 2024	Oct 06, 2024

Financials

Aasaan Loans IPO P/E ratio is , as compared to Emcure Pharma IPO P/E ratio of 34.55.

Aasaan Loans IPO

Emcure Pharma IPO

Financial

Akme Fintrade India Ltd Financial Information (Restated)

Akme Fintrade India Ltd's revenue increased by 3.06% and profit after tax (PAT) rose by 283.5% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Dec 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	417.96	390.50	374.01	455.40
Revenue	53.45	69.57	67.50	86.79
Profit After Tax	12.25	15.80	4.12	16.31
Net Worth	217.01	204.78	136.84	130.26
Reserves and Surplus	185.34	173.11	115.03	108.45
Total Borrowing	195.19	177.76	230.06	317.82
Amount in ₹ Crore

Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)

Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	7,806.16	6,672.53	6,063.47
Revenue	6,715.24	6,031.72	5,918.86
Profit After Tax	527.58	561.85	702.56
Net Worth	2,952.28	2,501.13	1,987.55
Reserves and Surplus	2,722.40	2,293.77	1,791.03
Total Borrowing	2,091.94	2,202.42	2,102.19
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

56.01%

98.90%

Promoter Shareholding (Post-Issue)

78.24%

P/E Ratio

34.55

Market Cap

₹19029.89 Cr.

ROE

5.64%%

16.90%%

ROCE

19.37%%

Debt/Equity

2.49

0.67

EPS

₹3.87

₹29.17

RoNW

5.81%%

16.87%%

Shares Offered

In the Aasaan Loans IPO retail investors (RII) are offered 36,57,500 shares while in Emcure Pharma IPO retail investors are offered 36,57,500 shares. Qualified institutional buyers (QIB) are offered 20,90,000 shares in Aasaan Loans IPO and 38,53,234 shares in Emcure Pharma IPO.

	Aasaan Loans IPO	Emcure Pharma IPO
Anchor Investor Reserveration	31,35,000 shares	57,79,850 shares
Market Maker Reserveration
QIB	20,90,000 shares	38,53,234 shares
NII	15,67,500 shares	28,89,926 shares
RII	36,57,500 shares	67,43,160 shares
Employee	5,50,000 shares	1,08,900 shares
Others
Total	78,65,000 shares	1,37,03,538 shares

Bids Received (Subscription)

Aasaan Loans IPO subscribed 54.49x in total, whereas Emcure Pharma IPO subscribed 67.87x.

	Aasaan Loans IPO	Emcure Pharma IPO
QIB (times)	28.12x	191.24x
NII (times)	129.98x	49.32x
Big NII (times)	121.56x	54.90x
Small NII (times)	146.83x	38.16x
RII (times)	44.58x	7.36x
Employee (times)	5.42x	8.81x
Other (times)
Total (times)	54.49x	67.87x

Compare with others

Aasaan Loans IPO	Emcure Pharma IPO
Sanstar IPO	Brainbees Solutions (Firstcry) IPO
Bansal Wire IPO	Ceigall India IPO
Emcure Pharma IPO	Akums Drugs and Pharmaceuticals IPO
OLA Electric IPO	Sanstar IPO
Vraj Iron and Steel IPO	Bansal Wire IPO
Stanley Lifestyles IPO	OLA Electric IPO
DEE Piping Systems IPO	Vraj Iron and Steel IPO
ixigo IPO	Aasaan Loans IPO
Kronox Lab Sciences IPO	Stanley Lifestyles IPO
Awfis Space Solutions IPO	DEE Piping Systems IPO

Comments

Add a public comment...